Copy and paste this code to insert a reference to this article in your
blog or online community profile:
 
 
Will Display Like this:
 
Alemtuzumab Equalizes Short Term Outcomes in High Risk PRA Patients: Long Term Outcomes Suffer
J Clin Exp Transplant 2017. 2:2, (2017)
https://doi.org/10.4172/2475-7640.1000117